Edwards Lifesciences Corporation (EW)
NYSE: EW · Real-Time Price · USD
72.98
+0.93 (1.29%)
At close: Apr 3, 2025, 4:00 PM
72.28
-0.70 (-0.96%)
Pre-market: Apr 4, 2025, 4:21 AM EDT
Edwards Lifesciences Revenue
In the year 2024, Edwards Lifesciences had annual revenue of $5.44B with 8.57% growth. Edwards Lifesciences had revenue of $1.39B in the quarter ending December 31, 2024, with 9.43% growth.
Revenue (ttm)
$5.44B
Revenue Growth
+8.57%
P/S Ratio
8.02
Revenue / Employee
$344,272
Employees
15,800
Market Cap
42.90B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5.44B | 429.50M | 8.57% |
| Dec 31, 2023 | 5.01B | 546.00M | 12.23% |
| Dec 31, 2022 | 4.46B | -768.50M | -14.69% |
| Dec 31, 2021 | 5.23B | 846.20M | 19.29% |
| Dec 31, 2020 | 4.39B | 38.30M | 0.88% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 400.28B |
| Johnson & Johnson | 88.82B |
| Merck & Co. | 64.17B |
| AbbVie | 56.33B |
| AstraZeneca | 54.07B |
| Novartis AG | 51.72B |
| Eli Lilly and Company | 45.04B |
| Thermo Fisher Scientific | 42.88B |
EW News
- 3 days ago - New Data Confirm Rapid, Unpredictable Progression of Severe Aortic Stenosis and Need for Urgent Referral and Evaluation of Patients - Business Wire
- 12 days ago - Edwards Lifesciences: Double-Digit Top Line And EPS Growth Ahead - Seeking Alpha
- 4 weeks ago - Scaling its Investment Platform in Minimally Invasive Care, Intuitive Ventures Appoints Terri Burke as Senior Partner and Ross Jaffe as Venture Advisor - Business Wire
- 5 weeks ago - Edwards Lifesciences to Present at the TD Cowen 45th Annual Health Care Conference - Business Wire
- 7 weeks ago - Heart Devices-Focused Edwards Lifesciences Confident in 2025 Outlook, Analyst Sees Long-Term Strength - Benzinga
- 7 weeks ago - Edwards Lifesciences Corporation (EW) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Edwards Lifesciences beats profit estimate on strength in heart devices - Reuters
- 7 weeks ago - Edwards Lifesciences Reports Fourth Quarter Results - Business Wire